Bronchiectasis News

BioNews, parent company of Bronchiectasis News Today, invites the members of our rare disease communities to join us in recognizing Rare Disease Day in February by answering the question, “Why does rare disease awareness matter to you?” Email your 150-200-word response to [email protected] along with two high-quality pictures of yourself that capture your “why.” We encourage you to share your response on your personal social media accounts tagging BioNews and using the hashtag . Throughout February, your submission could be featured on our social media channels! More info: https://buff.ly/3GTFXxH

New Post: European Initiative Targets Diagnosis, Treatment of Rare Diseases https://buff.ly/2O1Wk3f

European Initiative Targets Diagnosis, Treatment of Rare Diseases Learn more about the EU's €101 million initiative to speed the diagnosis of rare diseases and accelerate development of therapies in 35 countries.

New Post: Preclinical Data Supports Development of Inhaled Form of Murepavadin to Fight P. Aeruginosa Infections https://buff.ly/31TkQGu

Preclinical Data Shows Potential of Murepavadin Against P. Aeruginosa Preclinical data suggest that the experimental antibiotic murepavadin is both safe and effective at fighting restistant bacterial lung infections.

New Post: Bronchiectasis Patients Unlikely to Transmit Bacteria to Others Through Coughing, Study Suggests https://buff.ly/2WTQqoT

Bronchiectasis Patients' Coughing Unlikely to Spread Bacteria, Study Says Although bronchiectasis and COPD patients release bacteria during coughing, this process does not appear to spread infection to others, a study shows.